Supplementary Figure 6 from Proteogenomic Characterization Reveals Estrogen Signaling as a Target for Never-Smoker Lung Adenocarcinoma Patients without &lt;i&gt;EGFR&lt;/i&gt; or &lt;i&gt;ALK&lt;/i&gt; Alterations